ArticleEuropean journal of neurology2024

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Laura Zanandrea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.